H Huang, N Dong, L Shu, J Lu, Q Sun… - Emerging microbes & …, 2020 - Taylor & Francis
To investigate whether introduction of colistin into the clinical settings selected colistin- resistant CRE, we performed molecular epidemiological study of 1868 CRE strains collected …
JT Yang, LJ Zhang, Y Lu, RM Zhang… - Microbiology …, 2023 - Am Soc Microbiol
In recent years, bla CTX-M-55-positive Escherichia coli has been widely reported in multiple locations with an increasing trend in prevalence, yet few studies have comprehensively …
CTX‐M‐type extended‐spectrum β‐lactamase (ESBL)‐producing Escherichia coli clones have been increasingly reported worldwide. In this regard, although discussions of …
LP Nguyen, NA Pinto, TN Vu, H Lee, YL Cho, JH Byun… - Antibiotics, 2020 - mdpi.com
This study investigates GT-1 (also known as LCB10-0200), a novel-siderophore cephalosporin, inhibited multidrug-resistant (MDR) Gram-negative pathogen, via a Trojan …
S Oueslati, C Emeraud, V Grosperrin… - Antimicrobial agents …, 2021 - Am Soc Microbiol
The whole-genome sequencing analysis revealed a polyclonal dissemination of NDM-1 and NDM-9 variants in Escherichia coli (n= 20) and Klebsiella pneumoniae (n= 2) in Tahiti since …
LP Nguyen, CS Park, NA Pinto, H Lee, HS Seo, TN Vu… - Pharmaceuticals, 2021 - mdpi.com
The siderophore–antibiotic conjugate LCB10-0200 (aka GT-1) has been developed to combat multidrug-resistant Gram-negative bacteria. In this study, the in vitro activity of …
This study investigates GT-1 (also known as LCB10-0200), a novel-siderophore cephalosporin, inhibited multidrug-resistant (MDR) Gram-negative pathogen, via a Trojan …
[引用][C]Panel strain bank construction and characterization of gene network of β-lactam resistance in Escherichia coli clinical isolates, focusing on carbapenems and …